|
C3ORF17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.821400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.633840E-02 |
| Normal-vs-Stage2 |
3.042000E-02 |
| Normal-vs-Stage3 |
1.716840E-03 |
| Normal-vs-Stage4 |
2.902600E-03 |
| Stage1-vs-Stage2 |
3.631800E-01 |
| Stage1-vs-Stage3 |
1.618410E-01 |
| Stage1-vs-Stage4 |
1.467610E-01 |
| Stage2-vs-Stage3 |
9.086000E-01 |
| Stage2-vs-Stage4 |
7.977400E-01 |
| Stage3-vs-Stage4 |
8.534200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.763600E-04 |
| Normal-vs-AfricanAmerican |
7.018700E-03 |
| Normal-vs-Asian |
8.946400E-01 |
| Caucasian-vs-AfricanAmerican |
4.351800E-01 |
| Caucasian-vs-Asian |
4.548200E-01 |
| AfricanAmerican-vs-Asian |
2.981800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.35340000000117E-05 |
| Normal-vs-Female |
1.085820E-01 |
| Male-vs-Female |
1.469950E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.936400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.253900E-02 |
| Normal-vs-Age(61-80Yrs) |
3.95579999999951E-05 |
| Normal-vs-Age(81-100Yrs) |
4.153500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.688800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.143500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.301200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.356000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.039620E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.546000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.274200E-01 |
| Normal-vs-Grade 2 |
8.962000E-02 |
| Normal-vs-Grade 3 |
1.019520E-04 |
| Normal-vs-Grade 4 |
2.575400E-04 |
| Grade 1-vs-Grade 2 |
3.023600E-01 |
| Grade 1-vs-Grade 3 |
4.384400E-02 |
| Grade 1-vs-Grade 4 |
3.203600E-02 |
| Grade 2-vs-Grade 3 |
2.251700E-02 |
| Grade 2-vs-Grade 4 |
6.275400E-03 |
| Grade 3-vs-Grade 4 |
2.384200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.869600E-01 |
| Normal-vs-ccB subtype |
4.203700E-04 |
| ccA subtype-vs-ccB subtype |
2.180200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.236240E-02 |
| Normal-vs-N1 |
3.432800E-01 |
| N0-vs-N1 |
8.813800E-01 |
|
|
